Upgrade to SI Premium - Free Trial

BofA/Merrill Lynch Downgrades Puma Biotechnology (PBYI) to Underperform

November 2, 2018 9:18 AM
BofA/Merrill Lynch analyst Ying Huang downgraded Puma Biotechnology (NASDAQ: PBYI) from Buy to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change Downgrades Hot Downgrades

Next Articles